Jarbas Barbosa da Silva,
Emerging Infectious Diseases in Latin America
Dr. Jarbas Barbosa da Silva Jr. has been Manager of the Health Surveillance, Disease Prevention and Control Area of the Pan American Health Organization (PAHO) since 10 January 2007. The HSD area is responsible for coordinating regional activities on surveillance, prevention and control of communicable and non communicable diseases; health information and analysis; and veterinarian public health.
Dr. Barbosa received his degree in medicine from the Federal University of Pernambuco. He later received specialized credentials in public health and epidemiology from the National School of Public Health at the Oswaldo Cruz Foundation (FIOCRUZ), Brazil. He received a Master's degree and later a Doctoral degree in public health from the State University of Campinas (Unicamp) in São Paulo state, Brazil.
Dr. Barbosa began his professional career in the public health sector in 1982, working for the Secretariat of Health for the state of Pernambuco, Brazil. In 1987, he became Coordinator for the Program on Sexually Transmitted Diseases and HIV/AIDS in this state. In 1993, he was appointed Secretary of Health of the municipality of Olinda, and in 1995 Secretary of Health for the State of Pernambuco. In these positions he was the coordinator of the entire municipality health system and the state health system, respectively.
From 1997 to 2003, Dr. Barbosa da Silva worked as Director of the National Center for Epidemiology (CENEPI) in Brasilia, Brazil, in the Ministry of Health. In this position he was the national coordinator of the epidemiological surveillance system. In 2003 he was nominated as the first Secretary of Public Health Surveillance, a new branch created in the Brazilian MoH that jointed the areas of epidemiological surveillance and the prevention and control of diseases programmes. In the second semester of 2007 he was appointed as Executive Secretary (Vice Minister) of the Ministry of Health.
Dr. Barbosa is author and co-author of articles, books and chapters on several public health and epidemiological matters.
return to top
Françoise Barré-Sinoussi, FRANCE
Edward H. Kass Lecture
The Discovery of HIV: An Example of Translational
Research on Response to an Emerging Epidemic
Françoise Barré-Sinoussi, PhD, is the acting Director of
the "Regulation of Retroviral Infections" Unit at the Institut Pasteur
in Paris. She has been involved in retrovirology research
since the early 1970's and is recognized for her contributions to HIV/AIDS
research, in particular as the first author of the publication that reported
in 1983 the discovery of a retrovirus, later named HIV, in a patient at
risk for AIDS. Dr. Barré-Sinoussi shared the 2008 Nobel Prize in
Medicine with Dr. Luc Montagnier for their discovery of HIV. In 1988, she
became responsible for her own laboratory at the Institut Pasteur and initiated
research programs on viral and host determinants of HIV / AIDS pathogenesis.
Between 1988 and 1998, she has been involved in collaborative programs
on HIV vaccine research using primate models. Today, the research
programs of her team are focused on regulations of HIV / SIV infection
(intracellular restrictions of HIV-1infection and innate immunity,
in particular regulations of T cell activation resulting from the
NK-dendritic cell interplay).
Françoise Barré-Sinoussi is author and co-author of
more than 220 original publications andmore than 120 articles in book
reviews. She has been invited to speak at more than 250 International
meetings and/or conferences. She has been (and is still) a member
of a number of scientific committees in France and elsewhere, including
scientific committees of several International AIDS Conferences. She
has received 10 national or international awards for her contributions
to HIV/AIDS research.
Along with her research activities, since the early 80’s Françoise
Barré-Sinoussi has been strongly involved in promoting integration
between HIV/AIDS research and actions in resource limited countries,
in particular through the Institut Pasteur International Network and
the coordination of the ANRS research programs in Cambodia and Vietnam,
in accordance with her strong commitment to building capacity, training
and technology transfers on site in Africa and Asia.
return to top
Martin Cetron, USA (SLAMVI / ISTM Plenary Speaker)
The Changing Patterns of Global Migration and
the Impact on Infectious Diseases
Dr. Martin Cetron is the Director for the Division of Global Migration
and Quarantine (DGMQ) at the U.S. Centers for Disease Control and Prevention
(CDC). The DGMQ mission is to prevent introduction of infectious diseases
in the U.S. and to prevent morbidity among immigrants, refugees, migrant
workers, and international travelers.
Dr. Cetron received his M.D. from
Tufts University and trained in Infectious Diseases at
the University of Washington before joining the CDC's Epidemic Intelligence Service
His primary research interests are international health and global
migration with a focus on emerging infections, tropical
diseases, and vaccine-preventable diseases in mobile populations. He has
been in this current leadership role at CDC during responses to the key
emerging infectious disease outbreaks of the 21st century including the
anthrax bio-terrorism incident, the smallpox threat, the global SARS epidemic,
and the U.S. Monkeypox outbreak. He is part of the CDC Pandemic Influenza
planning and preparedness team and the WHO Influenza Pandemic Task Force.
return to top
Myron S. Cohen, USA
Richard K. Root Memorial Lecture
Transmission and Prevention of Transmission of HIV:
Clues from the Early 21st Century
Myron S. Cohen is the J. Herbert Bate Distinguished Professor
of Medicine, Microbiology and Immunology and Public Health at the University
of North Carolina at Chapel Hill. He is Associate Vice Chancellor for Medical
Affairs-Global Health. Dr. Cohen received his BS degree (Magna Cum Laude)
from the University of Illinois, Champaign-Urbana, an MD degree from Rush Medical
College, Chicago Illinois and he completed an Infectious Disease Fellowship
at Yale University.
Dr. Cohen serves as the Director of the UNC Division of Infectious Disease
and the UNC Institute for Global Health and Infectious Disease, and he is Associate
Director of the UNC Center for AIDS Research. Dr. Cohen serves on the
Senior Leadership Group of the NIH Center for HIV Vaccine Immunology (CHAVI),
and serves as part of the leadership group of the NIH HIV Prevention Trials
Network (HPTN). Dr. Cohen serves as an Associate Editor of the journal,
Sexually Transmitted Diseases, and the comprehensive textbook, Sexually
Dr. Cohen received the Distinguished Alumnus Award from Rush Medical
College in 2000. He received the Thomas Parran Award (2005) for lifetime
achievement in STD research from the American Sexually Transmitted Diseases
Association. In 2008 Dr. Cohen received the O. Max Gardner Award for "contributions
the greatest honor in the University of North Carolina 16
campus system. Doctor Cohen has been repeatedly recognized as one of America's "Top
Doctors" and "Best
Dr. Cohen's research work focuses on the transmission and prevention
of transmission of HIV, with emphasis on the role played
by STD co-infections. He has conducted landmark studies
related to the biology of HIV transmission and use of antiretroviral agents
for prevention. In 2005, Dr. Cohen received an NIH MERIT Award for ongoing
support of this work. Dr. Cohen is the author of more than 400 publications.
Much of Dr. Cohen's research has been conducted in internationally, especially
in the African country of Malawi and in the People's Republic
return to top
Keith Klugman, USA
Pneumococcal Infections in Children and their
Impact on Adults
Keith Klugman is the William H. Foege Chair of Global Health in the Hubert
Department of Global Health at the Rollins School of Public Health, Emory
University, in Atlanta, Georgia. He is a Professor of Medicine in the Division
of Infectious Diseases of the School of Medicine at Emory University and a
Visiting Researcher in the Respiratory Diseases Branch of the Centers for
Disease Control and Prevention (CDC). He is also the co-Director of the
Respiratory and Meningeal Pathogens Research Unit of the University of the
Witwatersrand, the Medical Research Council and the National Institute for
Communicable Diseases in Johannesburg, South Africa.
Professor Klugman is the Treasurer of the Executive Committee of the
International Society of Infectious Diseases, and Chair of the International
Board of the American Society for Microbiology. He has chaired expert committees
for the World Health Organization in Geneva and the Wellcome Trust in London,
and currently serves as an editor or member of the editorial board of 8
international journals on medicine, infectious diseases and antimicrobials.
Professor Klugman's research interests are in antibiotics, antimicrobial
resistance and vaccines for bacterial pathogens - particularly
the pneumococcus. He has published more than 375 papers on these subjects
return to top
Roberto Kolter, USA
Microbial Chemical Ecology and the Future of Antibiotics
Roberto Kolter has been a highly influential microbiologist for
a period that spans four decades. Early in his career he made enduring
advances in our understanding of the regulation of DNA replication
as well as practical advances in the development of the most widely
used "suicide delivery vectors" of today.
Since establishing his own laboratory at Harvard Medical School in
1983, Dr. Kolter has made contributions in diverse areas of microbiology.
Initially, he worked on peptide antibiotic synthesis and secretion,
providing some of the earliest knowledge on "ABC exporters". This was
followed by an exploration of the starvation physiology of E. coli at
a time when virtually no one else thought of investigating stationary
phase cultures. In part as a result of those efforts, the control of
gene expression in non-growing cells became an area of intense investigation
by others that continues to this day. Dr. Kolter's work on the population
dynamics of stationary phase cultures, the so-called
(growth advantage in stationary phase)
phenomenon, established such cultures as excellent model systems for
experimental evolution studies. Since the mid-1990's he has applied
genetic approaches to study bacterial biofilms; Dr. Kolter's laboratory
developed the most widely used high-throughput assay for detection
of biofilm development. His studies with Bacillus subtilis as
a model system to understand biofilms continue to be at the leading
edge of the field. Most recently, Dr. Kolter is investigating the chemistry
of interspecies communication in bacteria. In this area he discovered
that a bacterium's quorum sensing signal can also act as a fungal morphogen.
In addition, he has developed screens that have led to the discovery
of novel secondary metabolites produced by one species that profoundly
affect the developmental patterns of other species.
Since 2002, Dr. Kolter has played a key role in the organizing and
launching of the Microbial Sciences Initiative at Harvard (MSI) and
is currently its co-director. The MSI (www.msi.harvard.edu) is an innovative
University-wide interdisciplinary science program aimed at developing
new approaches to explore the microbial world. MSI is playing a leadership
role in microbial sciences worldwide by bringing together scientists
from diverse backgrounds to think about and discuss key issues in microbiology.
Presently, Dr. Kolter is the President-Elect of the American Society
for Microbiology and will become its President in July 2009.
return to top
Prof. Louis Loutan, SWITZERLAND
The Challenges of Travel Medicine in the 21st Century
Louis Loutan, MD, MPH is the head of the Division of International and
Humanitarian Medicine since its creation in the Department of Community Medicine
and Primary Care at the Geneva University Hospitals (HUG) in Geneva, Switzerland.
He is also Associate Professor in International and Humanitarian Medicine
at the University of Geneva. Dr. Loutan is a specialist in internal medicine
and tropical medicine and has a Master’s in Public Health from Harvard
Dr. Loutan has extensive field experience in international health projects
in Africa, the Balkans, Nepal and Central Asia conducting research projects
and organizing training programmes. He has spent five years in the Republic
of Niger running epidemiological surveys in nutrition and tropical medicine,
and organising programs in community health for nomadic populations. He spent
two years in the Department of Community Health at Tufts University School
of Medicine (Boston) organising training courses in international health.
He also served as technical advisor and coordinator of training and research
programmes in the family medicine reform in Bosnia & Herzegovina.
Dr. Loutan has been the founder and head of the Geneva travel and migration
medicine unit since 1991. He has conducted research in various aspects of
travel medicine including immunogenicity and tolerance of vaccines, security
and the health of humanitarian expatriates. The unit also offered various
services for migrants and refugees in Geneva, developing the new field of
migrant health. Dr. Loutan serves as senior consultant in tropical medicine
at the Geneva University Hospitals and as Medical Director of the HUG laboratory
His appointments included: president of the Swiss Society of Tropical Medicine
and Parasitology; president of the International Society of Travel Medicine;
board member of the Federation of European Societies for Tropical Medicine
and International Health; chair of the organising committee of the 5th International
Conference on Travel Medicine (Geneva 1997); president of the HUG Committee
of humanitarian and international cooperation activities; president of the
Geneva Forum: towards Global Access to Health, held in Geneva in 2006, 2008
and in preparation for 2010.
return to top
Christopher V. Plowe, USA
Christopher Plowe is a Howard Hughes Medical Institute Investigator and Professor
of Medicine, of Microbiology and Immunology, and of Epidemiology and Preventive
Medicine at the University of Maryland School of Medicine, where he is Chief
of the Malaria Section of the University's Center for Vaccine Development. Plowe
received his B.A. in Philosophy from Cornell University, an M.D. from Cornell
University Medical College, and an M.P.H. in Tropical Medicine from Columbia
University School of Public Health. He completed fellowships in Malaria Research
at the National Institutes of Health, USA and in Infectious Diseases at Johns
Hopkins University. He has received a Doris Duke Distinguished Clinical Scientist
Award and the Bailey K. Ashford Medal for distinguished work in tropical medicine
from the American Society of Tropical Medicine and Hygiene.
Dr. Plowe leads a multidisciplinary clinical translational malaria research
program with field sites in Mali, West Africa and Malawi, Central Africa. He
is best known for his work on the molecular epidemiology of drug resistant malaria.
Working with African colleagues, his group at the University of Maryland developed
rapid molecular assays to detect drug resistant malaria using dried blood spots
on paper. These tests have been used to understand the population genetics of
malaria and to control malaria outbreaks and inform treatment policy decisions.
Dr. Plowe's work encompasses malaria drug resistance, molecular epidemiology,
molecular evolution, rapid diagnostics, pathogenesis, immunology, international
research ethics, interactions between HIV and malaria, and clinical trials of
drugs and vaccines. His group is currently concentrating on understanding and
mitigating the impact of genetic diversity on malaria vaccine efficacy and on
developing strategies to deter the emergence and spread of drug resistant malaria.
Dr. Plowe directs the Molecular Module of the Worldwide Antimalarial Resistance
Network (WWARN). With colleagues in Mali, he has also designed and led several
clinical trials of malaria vaccines.
Dr. Plowe provides expert advice on malaria research and control to national
and international agencies and has testified before Congress on tropical medicine
research priorities and before a Presidential commission on international research
ethics. He divides his time between his laboratories in Baltimore, the Bandiagara
Malaria Project in Mali and the Blantyre Malaria Project in Malawi, and is developing
new collaborations in Southeast Asia. He is the author of more than 100 publications
return to top